SCHEMBL14795477

SCHEMBL14795477

CC(C)N1CCN(c2cc3[nH]c(-c4c(N)c5ccccc5[nH]c4=O)nc3cc2F)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 20/20 0.58
PDGFRB P09619 19/20 0.58
KDR P35968 19/20 0.58
FLT1 P17948 5/20 0.58
CHEK1 O14757 2/20 0.53
PLK4 O00444 1/20 0.49
STK25 O00506 1/20 0.49
CIT O14578 1/20 0.49
RIOK3 O14730 1/20 0.49
GAK O14976 1/20 0.49
CHUK O15111 1/20 0.49
MUSK O15146 1/20 0.49
EPHB6 O15197 1/20 0.49
PDPK1 O15530 1/20 0.49
MAP3K13 O43283 1/20 0.49
DAPK3 O43293 1/20 0.49
MAP3K7 O43318 1/20 0.49
NUAK1 O60285 1/20 0.49
PIP5K1C O60331 1/20 0.49
JAK2 O60674 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14795889 0.90 FGFR1 (0.62) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL14796437 0.89 FGFR1 (0.63) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL3379167 0.86 FGFR1 (0.72) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL3381351 0.84 FGFR1 (0.81) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL14795878 0.84 FGFR1 (0.52) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL3381735 0.83 FGFR1 (0.73) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL14795801 0.80 FGFR1 (0.75) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL3381513 0.79 FGFR1 (0.57) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL14795814 0.78 FGFR1 (0.77) FGFR1PDGFRBKDRFLT1CHEK1
SCHEMBL3383661 0.78 FGFR1 (0.71) FGFR1PDGFRBKDRFLT1CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2573079-A2 Benzimidazole quinolinones and uses thereof Novartis Vaccines and Diagnostics, Inc. (US) 2013-03-27 EP disclosed